Forza Wealth Management’s AbbVie ABBV Stock Holding History

Forza Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69M	Hold	10,703	–	–	0.83%	33
2026 Q1	$2.33M	Sell	10,703 -30	-0.3%	-$6.66K	0.81%	39
2025 Q4	$2.45M	Buy	10,733 +39	+0.4%	+$8.88K	0.89%	34
2025 Q3	$2.48M	Sell	10,694 -200	-2%	-$40.7K	0.95%	32
2025 Q2	$2.02M	Sell	10,894 -300	-3%	-$55.8K	0.83%	35
2025 Q1	$2.35M	Hold	11,194	–	–	1.05%	28
2024 Q4	$1.99M	Sell	11,194 -200	-2%	-$36.8K	0.91%	31
2024 Q3	$2.25M	Sell	11,394 -145	-1%	-$27.1K	1.03%	30
2024 Q2	$1.98M	Hold	11,539	–	–	1.02%	27
2024 Q1	$2.1M	Sell	11,539 -125	-1%	-$21.5K	1.09%	23
2023 Q4	$1.81M	Sell	11,664 -3,046	-21%	-$444K	1%	25
2023 Q3	$2.19M	Hold	14,710	–	–	1.13%	23
2023 Q2	$1.98M	Buy	14,710 +232	+2%	+$34K	1%	25
2023 Q1	$2.31M	Buy	14,478 +4,361	+43%	+$667K	1.19%	22
2022 Q4	$1.64M	Buy	+10,117	New	+$1.55M	1.08%	26

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Forza Wealth Management's ABBV Position: Q2 2026 in Review

Forza Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 10,703 shares worth $2.69M. The position accounts for 0.83% of the portfolio, ranked #33.

Forza Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Forza Wealth Management held 10,703 shares of AbbVie worth $2.69M as of Q2 2026.
Forza Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.83% of Forza Wealth Management's portfolio in Q2 2026, its #33 holding.
Forza Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Forza Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.